Selected Publications
1. Berven, S., Zurakowski, D., Mankin, H.J., Gebhardt, M.C., Springfield,
D.S. & Hornicek, F.J. (2002). Clinical outcome in chordoma: utility of
flow cytometry in DNA determination. Spine, 27, 374-9.
2. Buckwalter, J.A., Martin, J. & Mankin, H.J. (2000). Synovial joint
degeneration and the syndrome of osteoarthritis. Instr Course Lect, 49, 481-9.
3. Hornicek, F.J., Gebhardt, M.C., Wolfe, M.W., Kharrazi, F.D., Takeshita,
H., Parekh, S.G., Zurakowski, D. & Mankin, H.J. (2000). P-glycoprotein
levels predict poor outcome in patients with osteosarcoma. Clin Orthop, 11-7.
4. Mankin, H.J., Rosenthal, D.I. & Xavier, R. (2001). Gaucher disease.
New approaches to an ancient disease. J Bone Joint Surg Am, 83-A, 748-62.
5. Sullivan, L.G., Hasan, T., Wright, M., Mankin, H.J. & Towle, C.A. (2002).
Photodynamic treatment has chondroprotective effects on articular cartilage.
J Orthop Res, 20, 241-8.
6. Takeshita, H., Kusuzaki, K., Ashihara, T., Gebhardt, M.C., Mankin, H.J.
& Hirasawa, Y. (2000a). Intrinsic resistance to chemotherapeutic agents
in murine osteosarcoma cells. J Bone Joint Surg Am, 82-A, 963-9.
7. Takeshita, H., Kusuzaki, K., Kuzuhara, A., Tsuji, Y., Ashihara, T., Gebhardt,
M.C., Mankin, H.J., Springfield, D.S. & Hirasawa, Y. (2001). Relationship
between histologic grade and cytofluorometric cellular DNA and RNA content
in primary bone tumors. Anticancer Res, 21, 1271-7.
8. Takeshita, H., Kusuzaki, K., Murata, H., Suginoshita, T., Hirata, M., Hashiguchi,
S., Ashihara, T., Gebhardt, M.C., Mankin, H.J. & Hirasawa, Y. (2000b).
Osteoblastic differentiation and P-glycoprotein multidrug resistance in a
murine osteosarcoma model. Br J Cancer, 82, 1327-31.
9. Yin, H., Morioka, H., Towle, C.A., Vidal, M., Watanabe, T. & Weissbach,
L. (2001). Evidence that HAX-1 is an interleukin-1 alpha N-terminal binding
protein. Cytokine, 15, 122-37.